HEALTHglobal
Bicycle to lay off 30% of staff, pivot away from Padcev challenger
Single source
Updated 2 hours ago
First seen March 18, 2026 07:07:00Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
The company now expects a longer path to approval than anticipated, leading it to deprioritize a therapy billed as a threat to Pfizer’s fast-selling bladder cancer drug.